rs794728832
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PP2PP3_ModeratePP5_Very_Strong
The NM_001035.3(RYR2):c.14885A>G(p.Tyr4962Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y4962N) has been classified as Uncertain significance.
Frequency
Consequence
NM_001035.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RYR2 | NM_001035.3 | c.14885A>G | p.Tyr4962Cys | missense_variant | 105/105 | ENST00000366574.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RYR2 | ENST00000366574.7 | c.14885A>G | p.Tyr4962Cys | missense_variant | 105/105 | 1 | NM_001035.3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 15, 2011 | This variant is denoted Tyr4962Cys (aka Y4962C) at the protein level and c.14885 A>G at the cDNA level. The Tyr4962Cys variant in the RYR2 gene results in a semi-conservative amino acid substitution of a neutral, polar Tyrosine residue with a neutral, polar Cysteine that can affect disulfide bonds and protein structure. In addition, Tyrs4962 is a highly conserved position throughout evolution. In silico analysis predicts Tyr4962Cys is damaging to the protein structure/function (Adzhubei IA et al., 2010; Schwarz JM et al., 2011). Furthermore, Tyr4962Cys was reported in a genotype-positive individual with a family history of CPVT (van der Werf et al., 2011). The NHLBI ESP Exome Variant Server reports Tyr4962Cys was not observed in approximately 4,700 individuals from European and African American backgrounds, indicating it is not a common benign polymorphism in these populations. Nevertheless, Tyr4962Cys does not reside in one of the three mutation hot spot regions of the RYR2 gene (Medeiros-Domingo A et al., 2009). Therefore, we cannot definitively determine the clinical significance of the Tyr4962Cys variant, though evidence suggests it is disease-causing. The variant is found in CPVT panel(s). - |
Catecholaminergic polymorphic ventricular tachycardia 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 10, 2023 | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 4962 of the RYR2 protein (p.Tyr4962Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of catecholaminergic polymorphic ventricular tachycardia (CPVT) (PMID: 22787013, 31112425; Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 201405). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR2 protein function. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at